Sign in
WithdrawnNo phase

Diabetic Cardiomyopathy and Heart Failure

Key facts

Who runs it
University of Louisville
Where
Louisville, United StatesSee the site
Trial code
Status
Withdrawn
Started
Jul 2025
Ended
Jun 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Probiotic
Record updated
31 January 2025
Why it stopped
Did not receive funding as anticipated.

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • -Diabetic subjects with high blood glucose levels

Who cannot take part

  • Comorbidities affecting glucose levels and cardiac function

Where in United States

  • University of Louisville School of MedicineLouisville, United States

About the trial

What the trial wants to find out

This study will demonstrate the beneficial effects of ketone bodies in type 1 diabetes (T1D) patients and will have significant translational applications to prevent serious metabolic conditions such as T1D induced diabetic cardiomyopathy (DCM).

The 2 groups in the trial

  • Control subjects (non-diabetic).Other group

    Control subjects (non-diabetic): 10 subjects: No intervention (placebo). 10 subjects: Intervention (probiotic)

    Treatment: Probiotic

  • Diabetic SubjectsOther group

    Diabetic subjects: 10 subjects: No intervention (placebo). 10 subjects: Intervention (probiotic)

    Treatment: Probiotic

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Preventing Diabetic Cardiomyopathy and Heart Failure by Ketone Bodies
Record updated
31 January 2025